云南高校图书馆联盟文献共享服务平台- ASTRAZENECA

检索规则说明：AND代表“并且”；OR代表“或者”；NOT代表“不包含”；(注意必须大写,运算符两边需空一格)

检索范例：范例一： (K=图书馆学 OR K=情报学) AND A=范并思　　　　范例二：J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual

全部期刊核心期刊 EI来源期刊 SCI来源期刊 CA来源期刊 CSCD来源期刊 CSSCI来源期刊

Adverse Events following AstraZeneca COVID-19 Vaccination: A Case Study in Abidjan, Côte d’Ivoire: 《Open Journal of Immunology》2024年第2期11-15,共5页Chiayé Claire Antoinette Yapo-Crezoit Samuel Boahene Mireille Dosso; Introduction: Pharmaceutical companies have boosted vaccine production following the global COVID-19 pandemic. In Côte d’Ivoire, the first vaccination campaign with the AstraZeneca vaccine began on March 1, 2021, as ...; 关键词：Adverse Events Post-Second Immunization AstraZeneca Vaccine ABIDJAN

Arterial and Venous Thrombosis following Vaccination against COVID-19 with Astra-Zeneca Vaccine Revealing Thrombophilia: 《World Journal of Cardiovascular Diseases》2023年第4期198-204,共7页Bah Mamadou Bassirou Doumbouya Amadou Dioulde Balde Mamadou Aliou Balde Thierno Hamidou Sylla Ibrahima Sory Balde Elhadj Yaya Kone Alpha Barry Ibrahima Sory Samoura Sana Beavogui Mariam Diakité Souleymane Balde Mamadou Dadhi; Vaccination against COVID-19 is the most recognised means of containing the pandemic. Vaccines are not without side effects, particularly vascular thrombosis. But before blaming the vaccines, a thorough assessment of ...; 关键词：THROMBOPHILIA THROMBOSIS VACCINE ASTRAZENECA

Recurrent Coronary Artery Thrombosis on Triple Anti-Thrombotic Therapy, Is There a Possible Association with ChAdOx1 nCoV-19 Vaccination?: 《Case Reports in Clinical Medicine》2022年第6期234-243,共10页Phillip Crane Voltaire Nadurata M. Asrar Ul Haq; Background: Vaccines remain the only viable and safe option to control transmission and minimise disease sequelae during the COVID-19 pandemic. Whilst multiple vaccines are available, evidence has emerged regarding th...; 关键词：ST-Elevation Myocardial Infarction Stent Thrombosis ChAdOx1 nCoV-19 ASTRAZENECA COVID-19 SARS-CoV-2

Phenotypic appearance of central retinal vein occlusion post AstraZeneca vaccine: 《International Journal of Ophthalmology(English edition)》2022年第4期672-673,共2页Peter Cackett Rinoza Bafiq Ahmed Ali Su Ling Young; Dear Editor, The COVID-19 pandemic has brought about the development of novel vaccines at a rapid pace. The Astra Zeneca(AZ) COVID-19 adenovirus vector vaccine has been associated with thrombotic complications, the mo...; 关键词：VACCINE CEREBRAL OCCLUSION

Down Protein C and S Antigen Could Be Predictor of Mortality Outcome in Critical Egyptian COVID-19 Illness: 《Journal of Biosciences and Medicines》2022年第3期190-202,共13页Nadia El Menshawy Ghada Elsaid Tarek Abo Zeid Nora A. Farag; Background: One of the most serious morbidity and mortality features in COVID-19 is thrombo-embolic manifestation with disturbed hemostasis in natural anticoagulant. Protein S plays a critical role in cytokine stormin...; 关键词：Protein C S COVID-19 AstraZeneca Vaccine

布地奈德混悬液雾化吸入治疗儿童急性上呼吸道感染疗效分析被引量：7: 《中国医药导刊》2011年第12期2146-2147,共2页韩泽利周成勇严清红; 目的:探讨布地奈德混悬液(普米克令舒)雾化吸入治疗儿童急性上呼吸道炎症临床疗效。方法:急性上呼吸道感染患儿180例,随机分成3组(每组60例),分别采用常规抗炎组(A组),常规抗炎组+雾化吸入地塞米松和盐酸氨溴索(沐舒坦)(B组),常规抗炎组...; 关键词：急性上呼吸道感染儿童普米克令舒(厂家Astrazeneca Pty Ltd批号312286)

AstraZeneca／Astex合作遴选Alzheimer氏病候选药: 《国外药讯》2010年第12期11-11,共1页; AstraZeneca公司从与英国私有的生物技术公司Astex合作的药物发现项目中选择出一个候选物。该合作项目旨在寻找一种新型的β-分泌酶小分子抑制物，β-分泌酶是涉及Alzheimer氏病进展的一个重要的酶。; 关键词：ALZHEIMER氏病合作项目 AstraZeneca公司 Β-分泌酶选药病候遴选生物技术公司

AstraZeneca计划开展Brilique对心脏病的研究: 《国外药讯》2010年第11期10-10,共1页黄晓燕（译）; AstraZeneca公司预备在今年年底之前开始为其口服抗血小板药Brilique（ticagrelor）（I）的新研究招募患者。; 关键词：AstraZeneca公司心脏病抗血小板药

AstraZeneca向欧盟递交Axanum的申请: 《国外药讯》2010年第7期9-10,共2页黄晓燕（译）; AstraZeneca公司向欧洲管理当局提交固定剂量复方制剂Axanum（20mg esomeprazole／81mg阿司匹林）（Ⅰ）的新药申请。; 关键词：AstraZeneca公司 ESOMEPRAZOLE 固定剂量复方制剂欧盟新药申请阿司匹林

神经系统用药—AstraZeneca／Targacept公司开始TC-5214的Ⅲ期临床: 《国外药讯》2010年第7期13-13,共1页黄晓燕（译）; AstraZeneca公司与Targacept公司开始为抑郁症新药TC-5214（Ⅰ）的Ⅲ期试验招募患者。; 关键词：神经系统用药 AstraZeneca公司 Ⅲ期临床 Ⅲ期试验抑郁症

ASTRAZENECA